Efficacy of seasonal allergic rhinitis using an 810 nm diode laser system

Katsumi Sasaki, Takafumi Ohshiro, Reiko Sakio, Masahiro Toriumi, Asako Hatano, Emi Fukazawa, Takeyuki Kono, Keisuke Yoshihama, Kaoru Ogawa, Toshio Ohshiro

Research output: Contribution to journalArticle

Abstract

Background and Aims: Allergic rhinitis annually reach epidemic proportions in Japan. Approximately 30 to 40% of the population suffers from allergic rhinitis during the spring season. Symptoms comprise rhinorrhea, nasal congestion, and sneezing accompanied by irritation and itching of the eyes. The Ohshiro Clinic started using the conventional Nd:YAG laser for the treatment of allergic rhinitis in 1993, and from 2005 we started using a diode laser-pumped Nd:YAG laser. From 2010, we adopted a novel 810 nm diode laser, and the present retrospective study examined the efficacy rate of the treatment of allergic rhinitis in the 2018 season with this system, compared with a previous study in 2011. We aimed to confirm the degree of improvement for each symptom to evaluate effectiveness of the diode laser treatment. Subjects and methods: Between January 8, 2018 and April 30, 2018, a large number of patients consulted our clinic with the major complaint of seasonal allergic rhinitis. They underwent a blood test, and the antigen-specific serum IgE antibody titers were measured for a definitive diagnosis of cedar pollinosis. A total of 211 target patients were treated during the trial period. The average age of the target group was 36.3 years, 134 males, and 77 females. The target patients were treated with lower nasal turbinate mucosal irradiation using a diode laser (ADL-20, Asuka Medical) delivering 810 nm at 7.5 W, with a total energy per treatment of 240 J/cm2. We adopted a five-step evaluation in accordance with the Japanese Guidelines for Allergic Rhinitis 2014 for the symptoms of rhinorrhea, sneezing and nasal obstruction. We assessed the degree of improvement in the severity of these symptoms following diode laser treatment from baseline to one month after treatment, in addition to assessing patient satisfaction with the degree of improvement in their quality of life (QOL). Results: The 211 patients positive for cedar pollinosis by the antigen-specific serum IgE antibody tests were broken down by month by number and by improvement, no change or exacerbation as follows. January, 18 patients: 33.4%, 44.4% and 22.2%, respectively. February, 29: 10.4%, 44.4% and 22.2%, respectively. March, 146: 60.3%, 31.5% and 8.2%, respectively. April, 18: 77.8%, 16.7% and 5.5%, respectively. The monthly respective improvement, no change or worse patient QOL as percentages were as follows: January: 16.7%, 44.4% and 38.9%. February: 17.3%, 13.8% and 68.9%. March: 61.6%, 29.5% and 8.9%. April: 94.4%, 0.0% and 5.6%. The values for prevention of exacerbation versus exacerbation for each month were: January, 77.8% vs 22.2%; February, 41.4% vs 58.6%; March, 91.8% vs 8.2%; and April, 94.4% vs 5.6%. The mean efficacy rate for the trial period in the present study was therefore 52.6% which compared very favorably with the mean efficacy rate in the 2011 study of 53.4%. Conclusions: The results showed that the 810 nm diode laser offered a safe and effective solution for the uncomfortable symptoms of allergic rhinitis and could be well applied during the season of Japanese cedar pollen dispersion. Furthermore, a tendency towards high efficacy was demonstrated for laser treatment in class 6 cedar pollinosis patients, based on the specific IgE antibody test.

Original languageEnglish
Pages (from-to)11-18
Number of pages8
JournalLaser Therapy
Volume28
Issue number1
DOIs
Publication statusPublished - 2019 Jan 1

Fingerprint

Semiconductor Lasers
Seasonal Allergic Rhinitis
Semiconductor lasers
Antibodies
Immunoglobulin E
Sneezing
Antigens
Solid-State Lasers
Lasers
Nose
Therapeutics
Quality of Life
Cryptomeria
Turbinates
Nasal Obstruction
Hematologic Tests
Pruritus
Activities of Daily Living
Pollen
Serum

Keywords

  • Anti-histamine
  • Cedar pollinosis
  • Diode laser
  • Immunoglobulin E
  • RAST test
  • Seasonal Allergic Rhinitis
  • Type 1 allergic reaction

ASJC Scopus subject areas

  • Surgery
  • Biomedical Engineering

Cite this

Sasaki, K., Ohshiro, T., Sakio, R., Toriumi, M., Hatano, A., Fukazawa, E., ... Ohshiro, T. (2019). Efficacy of seasonal allergic rhinitis using an 810 nm diode laser system. Laser Therapy, 28(1), 11-18. https://doi.org/10.5978/islsm.28_19-OR-01

Efficacy of seasonal allergic rhinitis using an 810 nm diode laser system. / Sasaki, Katsumi; Ohshiro, Takafumi; Sakio, Reiko; Toriumi, Masahiro; Hatano, Asako; Fukazawa, Emi; Kono, Takeyuki; Yoshihama, Keisuke; Ogawa, Kaoru; Ohshiro, Toshio.

In: Laser Therapy, Vol. 28, No. 1, 01.01.2019, p. 11-18.

Research output: Contribution to journalArticle

Sasaki, K, Ohshiro, T, Sakio, R, Toriumi, M, Hatano, A, Fukazawa, E, Kono, T, Yoshihama, K, Ogawa, K & Ohshiro, T 2019, 'Efficacy of seasonal allergic rhinitis using an 810 nm diode laser system', Laser Therapy, vol. 28, no. 1, pp. 11-18. https://doi.org/10.5978/islsm.28_19-OR-01
Sasaki K, Ohshiro T, Sakio R, Toriumi M, Hatano A, Fukazawa E et al. Efficacy of seasonal allergic rhinitis using an 810 nm diode laser system. Laser Therapy. 2019 Jan 1;28(1):11-18. https://doi.org/10.5978/islsm.28_19-OR-01
Sasaki, Katsumi ; Ohshiro, Takafumi ; Sakio, Reiko ; Toriumi, Masahiro ; Hatano, Asako ; Fukazawa, Emi ; Kono, Takeyuki ; Yoshihama, Keisuke ; Ogawa, Kaoru ; Ohshiro, Toshio. / Efficacy of seasonal allergic rhinitis using an 810 nm diode laser system. In: Laser Therapy. 2019 ; Vol. 28, No. 1. pp. 11-18.
@article{5a070e8ddaec40878c73ab0241174f8f,
title = "Efficacy of seasonal allergic rhinitis using an 810 nm diode laser system",
abstract = "Background and Aims: Allergic rhinitis annually reach epidemic proportions in Japan. Approximately 30 to 40{\%} of the population suffers from allergic rhinitis during the spring season. Symptoms comprise rhinorrhea, nasal congestion, and sneezing accompanied by irritation and itching of the eyes. The Ohshiro Clinic started using the conventional Nd:YAG laser for the treatment of allergic rhinitis in 1993, and from 2005 we started using a diode laser-pumped Nd:YAG laser. From 2010, we adopted a novel 810 nm diode laser, and the present retrospective study examined the efficacy rate of the treatment of allergic rhinitis in the 2018 season with this system, compared with a previous study in 2011. We aimed to confirm the degree of improvement for each symptom to evaluate effectiveness of the diode laser treatment. Subjects and methods: Between January 8, 2018 and April 30, 2018, a large number of patients consulted our clinic with the major complaint of seasonal allergic rhinitis. They underwent a blood test, and the antigen-specific serum IgE antibody titers were measured for a definitive diagnosis of cedar pollinosis. A total of 211 target patients were treated during the trial period. The average age of the target group was 36.3 years, 134 males, and 77 females. The target patients were treated with lower nasal turbinate mucosal irradiation using a diode laser (ADL-20, Asuka Medical) delivering 810 nm at 7.5 W, with a total energy per treatment of 240 J/cm2. We adopted a five-step evaluation in accordance with the Japanese Guidelines for Allergic Rhinitis 2014 for the symptoms of rhinorrhea, sneezing and nasal obstruction. We assessed the degree of improvement in the severity of these symptoms following diode laser treatment from baseline to one month after treatment, in addition to assessing patient satisfaction with the degree of improvement in their quality of life (QOL). Results: The 211 patients positive for cedar pollinosis by the antigen-specific serum IgE antibody tests were broken down by month by number and by improvement, no change or exacerbation as follows. January, 18 patients: 33.4{\%}, 44.4{\%} and 22.2{\%}, respectively. February, 29: 10.4{\%}, 44.4{\%} and 22.2{\%}, respectively. March, 146: 60.3{\%}, 31.5{\%} and 8.2{\%}, respectively. April, 18: 77.8{\%}, 16.7{\%} and 5.5{\%}, respectively. The monthly respective improvement, no change or worse patient QOL as percentages were as follows: January: 16.7{\%}, 44.4{\%} and 38.9{\%}. February: 17.3{\%}, 13.8{\%} and 68.9{\%}. March: 61.6{\%}, 29.5{\%} and 8.9{\%}. April: 94.4{\%}, 0.0{\%} and 5.6{\%}. The values for prevention of exacerbation versus exacerbation for each month were: January, 77.8{\%} vs 22.2{\%}; February, 41.4{\%} vs 58.6{\%}; March, 91.8{\%} vs 8.2{\%}; and April, 94.4{\%} vs 5.6{\%}. The mean efficacy rate for the trial period in the present study was therefore 52.6{\%} which compared very favorably with the mean efficacy rate in the 2011 study of 53.4{\%}. Conclusions: The results showed that the 810 nm diode laser offered a safe and effective solution for the uncomfortable symptoms of allergic rhinitis and could be well applied during the season of Japanese cedar pollen dispersion. Furthermore, a tendency towards high efficacy was demonstrated for laser treatment in class 6 cedar pollinosis patients, based on the specific IgE antibody test.",
keywords = "Anti-histamine, Cedar pollinosis, Diode laser, Immunoglobulin E, RAST test, Seasonal Allergic Rhinitis, Type 1 allergic reaction",
author = "Katsumi Sasaki and Takafumi Ohshiro and Reiko Sakio and Masahiro Toriumi and Asako Hatano and Emi Fukazawa and Takeyuki Kono and Keisuke Yoshihama and Kaoru Ogawa and Toshio Ohshiro",
year = "2019",
month = "1",
day = "1",
doi = "10.5978/islsm.28_19-OR-01",
language = "English",
volume = "28",
pages = "11--18",
journal = "Laser Therapy",
issn = "0898-5901",
publisher = "World Association for Laser Therapy",
number = "1",

}

TY - JOUR

T1 - Efficacy of seasonal allergic rhinitis using an 810 nm diode laser system

AU - Sasaki, Katsumi

AU - Ohshiro, Takafumi

AU - Sakio, Reiko

AU - Toriumi, Masahiro

AU - Hatano, Asako

AU - Fukazawa, Emi

AU - Kono, Takeyuki

AU - Yoshihama, Keisuke

AU - Ogawa, Kaoru

AU - Ohshiro, Toshio

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Background and Aims: Allergic rhinitis annually reach epidemic proportions in Japan. Approximately 30 to 40% of the population suffers from allergic rhinitis during the spring season. Symptoms comprise rhinorrhea, nasal congestion, and sneezing accompanied by irritation and itching of the eyes. The Ohshiro Clinic started using the conventional Nd:YAG laser for the treatment of allergic rhinitis in 1993, and from 2005 we started using a diode laser-pumped Nd:YAG laser. From 2010, we adopted a novel 810 nm diode laser, and the present retrospective study examined the efficacy rate of the treatment of allergic rhinitis in the 2018 season with this system, compared with a previous study in 2011. We aimed to confirm the degree of improvement for each symptom to evaluate effectiveness of the diode laser treatment. Subjects and methods: Between January 8, 2018 and April 30, 2018, a large number of patients consulted our clinic with the major complaint of seasonal allergic rhinitis. They underwent a blood test, and the antigen-specific serum IgE antibody titers were measured for a definitive diagnosis of cedar pollinosis. A total of 211 target patients were treated during the trial period. The average age of the target group was 36.3 years, 134 males, and 77 females. The target patients were treated with lower nasal turbinate mucosal irradiation using a diode laser (ADL-20, Asuka Medical) delivering 810 nm at 7.5 W, with a total energy per treatment of 240 J/cm2. We adopted a five-step evaluation in accordance with the Japanese Guidelines for Allergic Rhinitis 2014 for the symptoms of rhinorrhea, sneezing and nasal obstruction. We assessed the degree of improvement in the severity of these symptoms following diode laser treatment from baseline to one month after treatment, in addition to assessing patient satisfaction with the degree of improvement in their quality of life (QOL). Results: The 211 patients positive for cedar pollinosis by the antigen-specific serum IgE antibody tests were broken down by month by number and by improvement, no change or exacerbation as follows. January, 18 patients: 33.4%, 44.4% and 22.2%, respectively. February, 29: 10.4%, 44.4% and 22.2%, respectively. March, 146: 60.3%, 31.5% and 8.2%, respectively. April, 18: 77.8%, 16.7% and 5.5%, respectively. The monthly respective improvement, no change or worse patient QOL as percentages were as follows: January: 16.7%, 44.4% and 38.9%. February: 17.3%, 13.8% and 68.9%. March: 61.6%, 29.5% and 8.9%. April: 94.4%, 0.0% and 5.6%. The values for prevention of exacerbation versus exacerbation for each month were: January, 77.8% vs 22.2%; February, 41.4% vs 58.6%; March, 91.8% vs 8.2%; and April, 94.4% vs 5.6%. The mean efficacy rate for the trial period in the present study was therefore 52.6% which compared very favorably with the mean efficacy rate in the 2011 study of 53.4%. Conclusions: The results showed that the 810 nm diode laser offered a safe and effective solution for the uncomfortable symptoms of allergic rhinitis and could be well applied during the season of Japanese cedar pollen dispersion. Furthermore, a tendency towards high efficacy was demonstrated for laser treatment in class 6 cedar pollinosis patients, based on the specific IgE antibody test.

AB - Background and Aims: Allergic rhinitis annually reach epidemic proportions in Japan. Approximately 30 to 40% of the population suffers from allergic rhinitis during the spring season. Symptoms comprise rhinorrhea, nasal congestion, and sneezing accompanied by irritation and itching of the eyes. The Ohshiro Clinic started using the conventional Nd:YAG laser for the treatment of allergic rhinitis in 1993, and from 2005 we started using a diode laser-pumped Nd:YAG laser. From 2010, we adopted a novel 810 nm diode laser, and the present retrospective study examined the efficacy rate of the treatment of allergic rhinitis in the 2018 season with this system, compared with a previous study in 2011. We aimed to confirm the degree of improvement for each symptom to evaluate effectiveness of the diode laser treatment. Subjects and methods: Between January 8, 2018 and April 30, 2018, a large number of patients consulted our clinic with the major complaint of seasonal allergic rhinitis. They underwent a blood test, and the antigen-specific serum IgE antibody titers were measured for a definitive diagnosis of cedar pollinosis. A total of 211 target patients were treated during the trial period. The average age of the target group was 36.3 years, 134 males, and 77 females. The target patients were treated with lower nasal turbinate mucosal irradiation using a diode laser (ADL-20, Asuka Medical) delivering 810 nm at 7.5 W, with a total energy per treatment of 240 J/cm2. We adopted a five-step evaluation in accordance with the Japanese Guidelines for Allergic Rhinitis 2014 for the symptoms of rhinorrhea, sneezing and nasal obstruction. We assessed the degree of improvement in the severity of these symptoms following diode laser treatment from baseline to one month after treatment, in addition to assessing patient satisfaction with the degree of improvement in their quality of life (QOL). Results: The 211 patients positive for cedar pollinosis by the antigen-specific serum IgE antibody tests were broken down by month by number and by improvement, no change or exacerbation as follows. January, 18 patients: 33.4%, 44.4% and 22.2%, respectively. February, 29: 10.4%, 44.4% and 22.2%, respectively. March, 146: 60.3%, 31.5% and 8.2%, respectively. April, 18: 77.8%, 16.7% and 5.5%, respectively. The monthly respective improvement, no change or worse patient QOL as percentages were as follows: January: 16.7%, 44.4% and 38.9%. February: 17.3%, 13.8% and 68.9%. March: 61.6%, 29.5% and 8.9%. April: 94.4%, 0.0% and 5.6%. The values for prevention of exacerbation versus exacerbation for each month were: January, 77.8% vs 22.2%; February, 41.4% vs 58.6%; March, 91.8% vs 8.2%; and April, 94.4% vs 5.6%. The mean efficacy rate for the trial period in the present study was therefore 52.6% which compared very favorably with the mean efficacy rate in the 2011 study of 53.4%. Conclusions: The results showed that the 810 nm diode laser offered a safe and effective solution for the uncomfortable symptoms of allergic rhinitis and could be well applied during the season of Japanese cedar pollen dispersion. Furthermore, a tendency towards high efficacy was demonstrated for laser treatment in class 6 cedar pollinosis patients, based on the specific IgE antibody test.

KW - Anti-histamine

KW - Cedar pollinosis

KW - Diode laser

KW - Immunoglobulin E

KW - RAST test

KW - Seasonal Allergic Rhinitis

KW - Type 1 allergic reaction

UR - http://www.scopus.com/inward/record.url?scp=85067065257&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85067065257&partnerID=8YFLogxK

U2 - 10.5978/islsm.28_19-OR-01

DO - 10.5978/islsm.28_19-OR-01

M3 - Article

VL - 28

SP - 11

EP - 18

JO - Laser Therapy

JF - Laser Therapy

SN - 0898-5901

IS - 1

ER -